SCHEMBL29455401

SCHEMBL29455401

COc1cc(-c2cccc(-c3cccc(NC(=O)c4cccn(C)c4=O)c3C)c2C)cc(F)c1CNCC(=O)O

nearest known ligand 0.75

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CD274 Q9NZQ7 20/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22659618 1.00 CD274 (0.75) CD274
SCHEMBL22762943 0.94 CD274 (0.73) CD274
SCHEMBL22762907 0.93 CD274 (0.72) CD274
SCHEMBL22659707 0.92 CD274 (0.80) CD274
SCHEMBL29455395 0.91 CD274 (0.75) CD274
SCHEMBL22659723 0.91 CD274 (0.75) CD274
SCHEMBL22679465 0.91 CD274 (0.78) CD274
SCHEMBL22660073 0.89 CD274 (0.76) CD274
SCHEMBL29455463 0.89 CD274 (0.76) CD274
SCHEMBL22659554 0.89 CD274 (0.71) CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3968996-A1 TRIARYL COMPOUNDS FOR TREATMENT OF PD-L1 DISEASES ChemoCentryx, Inc. (US) 2022-03-23 — — EP disclosed
Send feedback